dc.creatorRíos, José Luis
dc.creatorAndújar, Isabel
dc.creatorSchinella, Guillermo Raúl
dc.creatorFrancini, Flavio
dc.date.accessioned2021-01-12T12:52:44Z
dc.date.accessioned2022-10-15T12:40:43Z
dc.date.available2021-01-12T12:52:44Z
dc.date.available2022-10-15T12:40:43Z
dc.date.created2021-01-12T12:52:44Z
dc.date.issued2019-04
dc.identifierRíos, José Luis; Andújar, Isabel; Schinella, Guillermo Raúl; Francini, Flavio; Modulation of Diabetes by Natural Products and Medicinal Plants via Incretins; Georg Thieme Verlag Kg; Planta Medica; 85; 11-12; 4-2019; 825-839
dc.identifier0032-0943
dc.identifierhttp://hdl.handle.net/11336/122447
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4387178
dc.description.abstractIncretins are metabolic hormones released after a meal that increase insulin secretion from pancreatic β-cells. The two main incretins are the intestinal peptides glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. Both induce a decrease in glycemia, slow down the absorption of nutrients, and are inactivated by the enzyme dipeptidyl peptidase-4. Recently, incretin-based therapies have become a useful tool to treat diabetic patients, and different studies have focused on the identification of glucagon-like peptide-1 receptor agonists, including those of natural origin. This review focuses on the new findings of medicinal plants and natural products as possible active agents on the potentiation of incretin receptor signaling. Among these, soluble fiber from species of Plantago and guar gum show promising effects, iridoid derivatives are relevant activators of incretin receptors, and derivatives of cyanidin, especially diglycosylated ones, are an interesting source of dipeptidyl peptidase-4 inhibitors.
dc.languageeng
dc.publisherGeorg Thieme Verlag Kg
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1055/a-0897-7492
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-0897-7492
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDIPEPTIDYL PEPTIDASE-4
dc.subjectDPP-4
dc.subjectGIP
dc.subjectGLP-1
dc.subjectGLUCAGON-LIKE PEPTIDE-1
dc.subjectGLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE
dc.subjectINCRETINS
dc.titleModulation of Diabetes by Natural Products and Medicinal Plants via Incretins
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución